Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Migraine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 117 articles:
HTML format



Single Articles


    July 2021
  1. CARVALHO G, Mehnert J, Basedau H, Luedtke K, et al
    Brain Processing of a Visual Self-Motion Study in Patients With Migraine: An fMRI Study.
    Neurology. 2021 Jul 21. pii: WNL.0000000000012443.
    PubMed     Abstract available


    April 2021
  2. MACDONALD CJ, El Fatouhi D, Madika AL, Fagherazzi G, et al
    Association of Migraine With Incident Hypertension After Menopause: A Longitudinal Cohort Study.
    Neurology. 2021 Apr 21. pii: WNL.0000000000011986.
    PubMed     Abstract available


  3. GHANIZADA H, Al-Mahdi Al-Karagholi M, Arngrim N, Morch-Rasmussen M, et al
    Effect of Adrenomedullin on Migraine-like Attacks in Patients With Migraine: A Randomized Crossover Study.
    Neurology. 2021 Apr 7. pii: WNL.0000000000011930.
    PubMed     Abstract available


  4. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:686.
    PubMed    


  5. MINEN MT
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:685.
    PubMed    


  6. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:684-685.
    PubMed    


  7. BLUMENFELD A
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:684.
    PubMed    


  8. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:683-684.
    PubMed    


  9. GUPTA VK
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:683.
    PubMed    


  10. GANESH A, Galetta S
    Editors' Note: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:682.
    PubMed    


  11. GUO Y, Rist PM, Sabater Lleal M, de Vries P, et al
    Association Between Hemostatic Profile and Migraine: A Mendelian Randomization Analysis.
    Neurology. 2021 Apr 1. pii: WNL.0000000000011931.
    PubMed     Abstract available


    February 2021
  12. YU AYX, Hill MD, Asdaghi N, Boulanger JM, et al
    Sex Differences in Diagnosis and Diagnostic Revision of Suspected Minor Cerebral Ischemic Events.
    Neurology. 2021;96:e732-e739.
    PubMed     Abstract available


    January 2021
  13. VAN CASTEREN DS, Kurth T, Danser AHJ, Terwindt GM, et al
    Sex Differences in Response to Triptans: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:162-170.
    PubMed     Abstract available


    November 2020
  14. RIGGINS NY, Sawhney H, Ehrlich A, Parekh M, et al
    Inpatient infusion treatments of headache in patients with chronic migraine and a reported history of head trauma and endocrine co-morbidities.
    Neurology. 2020;95.
    PubMed     Abstract available


  15. ROBBINS MS, Victorio MC, Bailey M, Cook C, et al
    Quality improvement in neurology: Headache Quality Measurement Set.
    Neurology. 2020;95:866-873.
    PubMed    


    October 2020
  16. LIPTON RB, Fanning KM, Buse DC, Martin VT, et al
    Author response: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:707-708.
    PubMed    


  17. GUPTA VK
    Reader response: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:707.
    PubMed    


  18. SIEGLER JE 3RD, Galetta S
    Editors' note: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:706.
    PubMed    


  19. SASIKUMAR S, Micieli JA, Oh J
    Mystery Case: Migraine, hearing loss, and blurred vision in a young woman.
    Neurology. 2020 Oct 12. pii: WNL.0000000000011034.
    PubMed    


    September 2020
  20. ZIEGELER C, Mehnert J, Asmussen K, May A, et al
    Central effects of erenumab in migraine patients: An event-related functional imaging study.
    Neurology. 2020 Sep 11. pii: WNL.0000000000010740.
    PubMed     Abstract available


  21. GOADSBY PJ, Silberstein SD, Yeung PP, Cohen JM, et al
    LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF FREMANEZUMAB IN MIGRAINE: A RANDOMIZED STUDY.
    Neurology. 2020 Sep 10. pii: WNL.0000000000010600.
    PubMed     Abstract available


  22. KORNBLUH AB, Chung MG
    Teaching NeuroImages: Transient cytotoxic edema in a child with a novel ATP1A2 mutation.
    Neurology. 2020;95:e1441-e1442.
    PubMed    


    August 2020
  23. SALTER A, Kowalec K, Fitzgerald KC, Cutter G, et al
    Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
    Neurology. 2020;95:e446-e456.
    PubMed     Abstract available


  24. LIPTON RB, Cohen JM, Gandhi SK, Yang R, et al
    Effect of Fremanezumab on Quality of Life and Productivity in Patients With Chronic Migraine.
    Neurology. 2020 Aug 3. pii: WNL.0000000000010000.
    PubMed     Abstract available


    July 2020
  25. THALER AI, Kim BD, Fara MG
    Teaching NeuroImages: MR Perfusion and Diffusion Findings in Hemiplegic Migraine.
    Neurology. 2020 Jul 9. pii: WNL.0000000000010249.
    PubMed    


  26. GOADSBY PJ, Reuter U, Hallstrom Y, Broessner G, et al
    One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study.
    Neurology. 2020 Jul 7. pii: WNL.0000000000010019.
    PubMed     Abstract available


    June 2020
  27. LIPTON RB, Buse DC, Friedman BW, Feder L, et al
    Characterizing opioid use in a US population with migraine: Results from the CaMEO study.
    Neurology. 2020 Jun 11. pii: WNL.0000000000009324.
    PubMed     Abstract available


    May 2020

  28. Vascular safety of erenumab for migraine prevention.
    Neurology. 2020 May 7. pii: WNL.0000000000009310.
    PubMed    


  29. KUMAR A, Bhatia R, Sharma G, Dhanlika D, et al
    Effect of yoga as add-on therapy in migraine (CONTAIN): A randomized clinical trial.
    Neurology. 2020 May 6. pii: WNL.0000000000009473.
    PubMed     Abstract available


    April 2020
  30. SLAVOVA N, Denier N, El-Koussy M, Wiest R, et al
    The index vein pointing to the origin of the migraine aura symptom: A case series.
    Neurology. 2020 Apr 23. pii: WNL.0000000000009493.
    PubMed     Abstract available



  31. Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.
    Neurology. 2020 Apr 23. pii: WNL.0000000000009280.
    PubMed    


    March 2020
  32. LIPTON RB, Goadsby PJ, Smith J, Schaeffler BA, et al
    Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.
    Neurology. 2020 Mar 24. pii: WNL.0000000000009169.
    PubMed     Abstract available


    February 2020
  33. COSTELLO FE, Bisdorff AR, Robbins MS
    Visual snow: Are we beginning to see the light?
    Neurology. 2020;94:241-242.
    PubMed    


  34. PULEDDA F, Schankin C, Goadsby PJ
    Visual snow syndrome: A clinical and phenotypical description of 1,100 cases.
    Neurology. 2020;94:e564-e574.
    PubMed     Abstract available


  35. LEIRA R, Dominguez C
    Author response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:235-236.
    PubMed    


  36. WELCH KMA
    Reader response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:235.
    PubMed    


  37. GUPTA V
    Reader response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:234.
    PubMed    


  38. SHUBHAKARAN K
    Reader response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:233-234.
    PubMed    


  39. LEWIS A, Galetta S
    Editors' note: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:233.
    PubMed    


    January 2020
  40. ROCCA MA, Harrer JU, Filippi M
    Are machine learning approaches the future to study migraine patients?
    Neurology. 2020 Jan 21. pii: WNL.0000000000008956.
    PubMed    


  41. TU Y, Zeng F, Lan L, Li Z, et al
    An fMRI-based neural marker for migraine without aura.
    Neurology. 2020 Jan 21. pii: WNL.0000000000008962.
    PubMed     Abstract available


  42. MULLIN K, Kudrow D, Croop R, Lovegren M, et al
    Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.
    Neurology. 2020 Jan 13. pii: WNL.0000000000008944.
    PubMed     Abstract available


    December 2019
  43. KUDROW D, Pascual J, Winner PK, Dodick DW, et al
    Vascular safety of erenumab for migraine prevention.
    Neurology. 2019 Dec 18. pii: WNL.0000000000008743.
    PubMed     Abstract available


  44. BERTISCH SM, Li W, Buettner C, Mostofsky E, et al
    Nightly sleep duration, fragmentation, and quality and daily risk of migraine.
    Neurology. 2019 Dec 16. pii: WNL.0000000000008740.
    PubMed     Abstract available



  45. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Dec 10. pii: WNL.0000000000008728.
    PubMed    



  46. Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Dec 10. pii: WNL.0000000000008750.
    PubMed    


    November 2019
  47. TAN RYY, Traylor M, Megy K, Duarte D, et al
    How common are single gene mutations as a cause for lacunar stroke? A targeted gene panel study.
    Neurology. 2019 Nov 12. pii: WNL.0000000000008544.
    PubMed     Abstract available


  48. LIPTON RB, Fanning KM, Buse DC, Martin VT, et al
    Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2019 Nov 5. pii: WNL.0000000000008589.
    PubMed     Abstract available


    October 2019
  49. LAHUE SC, Gelfand AA, Bove RM
    Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good?
    Neurology. 2019;93:668-672.
    PubMed     Abstract available


  50. SEN S
    Author response: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2019;93:646-647.
    PubMed    


  51. HSIEH CY
    Reader response: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2019;93:646.
    PubMed    


  52. GUPTA V
    Reader response: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2019;93:645-646.
    PubMed    


  53. LEWIS A, Galetta S
    Editors' note: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2019;93:645.
    PubMed    


    September 2019
  54. BEH SC, Friedman DI
    Acute vestibular migraine treatment with noninvasive vagus nerve stimulation.
    Neurology. 2019 Sep 25. pii: WNL.0000000000008388.
    PubMed     Abstract available



  55. Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2019;93:608.
    PubMed    


    August 2019
  56. ZIEGELER C, May A
    Facial presentations of migraine, TACs, and other paroxysmal facial pain syndromes.
    Neurology. 2019 Aug 21. pii: WNL.0000000000008124.
    PubMed     Abstract available


  57. OSKOUI M, Pringsheim T, Holler-Managan Y, Potrebic S, et al
    Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Aug 14. pii: WNL.0000000000008095.
    PubMed     Abstract available


  58. OSKOUI M, Pringsheim T, Billinghurst L, Potrebic S, et al
    Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Aug 14. pii: WNL.0000000000008105.
    PubMed     Abstract available


  59. TEE TY, Khoo CS, Raymond AA, Syazarina SO, et al
    Teaching NeuroImages: Neuroimaging in hemiplegic migraine.
    Neurology. 2019;93:e626-e627.
    PubMed    


    July 2019
  60. VAN DONGEN RM, Waaijer LC, Onderwater GLJ, Ferrari MD, et al
    Treatment effects and comorbid diseases in 58 patients with visual snow.
    Neurology. 2019;93:e398-e403.
    PubMed     Abstract available


  61. ROBBINS MS
    Comment: Time for neurologists to see visual snow.
    Neurology. 2019;93:153.
    PubMed    


  62. ARKINK EB, Palm-Meinders IH, Koppen H, Milles J, et al
    Microstructural white matter changes preceding white matter hyperintensities in migraine.
    Neurology. 2019 Jul 11. pii: WNL.0000000000007940.
    PubMed     Abstract available


  63. FORD JH, Ayer DW, Zhang Q, Carter JN, et al
    Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability.
    Neurology. 2019 Jul 3. pii: WNL.0000000000007856.
    PubMed     Abstract available


    June 2019
  64. YOUNG AS, Lechner C, Bradshaw AP, MacDougall HG, et al
    Capturing acute vertigo: A vestibular event monitor.
    Neurology. 2019;92:e2743-e2753.
    PubMed     Abstract available


    May 2019
  65. TU Y, Fu Z, Zeng F, Maleki N, et al
    Abnormal thalamo-cortical network dynamics in migraine.
    Neurology. 2019 May 10. pii: WNL.0000000000007607.
    PubMed     Abstract available


  66. COPPOLA G, Di Renzo A, Petolicchio B, Tinelli E, et al
    Aberrant interactions of cortical networks in chronic migraine: A resting-state fMRI study.
    Neurology. 2019 May 3. pii: WNL.0000000000007577.
    PubMed     Abstract available


    April 2019
  67. LIPTON RB, Tepper SJ, Reuter U, Silberstein S, et al
    Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.
    Neurology. 2019 Apr 17. pii: WNL.0000000000007452.
    PubMed     Abstract available


  68. TEPPER SJ, Diener HC, Ashina M, Brandes JL, et al
    Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
    Neurology. 2019 Apr 17. pii: WNL.0000000000007497.
    PubMed     Abstract available


  69. ONDERWATER GLJ, Ligthart L, Bot M, Demirkan A, et al
    Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007313.
    PubMed     Abstract available


    March 2019
  70. ALBRECHT DS, Mainero C, Ichijo E, Ward N, et al
    Imaging of neuroinflammation in migraine with aura: A [(11)C]PBR28 PET/MRI study.
    Neurology. 2019 Mar 27. pii: WNL.0000000000007371.
    PubMed     Abstract available


  71. FILIPPI M, Messina R, Goadsby PJ, Rocca MA, et al
    Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:587-588.
    PubMed    


  72. GUPTA VK
    Reader response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:587.
    PubMed    


  73. SIEGLER JE 3RD, Galetta S
    Editors' note: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:586.
    PubMed    


  74. LAPUCCI C, Saitta L, Bommarito G, Sormani MP, et al
    How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
    Neurology. 2019 Mar 8. pii: WNL.0000000000007266.
    PubMed     Abstract available


    February 2019
  75. DOMINGUEZ C, Lopez A, Ramos-Cabrer P, Vieites-Prado A, et al
    Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2019 Feb 1. pii: WNL.0000000000007047.
    PubMed     Abstract available


    January 2019
  76. LEE MJ, Park BY, Cho S, Park H, et al
    Cerebrovascular reactivity as a determinant of deep white matter hyperintensities in migraine.
    Neurology. 2019 Jan 4. pii: WNL.0000000000006822.
    PubMed     Abstract available


    December 2018
  77. GELAYE B, Sacco S, Brown W, Nitchie H, et al
    Author response: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1074.
    PubMed    


  78. GUPTA VK
    Reader response: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1073.
    PubMed    


  79. LEWIS A, Galetta S
    Editors' note: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1073.
    PubMed    


    November 2018
  80. REISMAN AM, Robbins BT, Chou DE, Yugrakh MS, et al
    Ticagrelor for Refractory Migraine/Patent Foramen Ovale (TRACTOR): An open-label pilot study.
    Neurology. 2018;91:1010-1017.
    PubMed     Abstract available


  81. SOMMER RJ, Nazif T, Privitera L, Robbins BT, et al
    Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale.
    Neurology. 2018;91:1002-1009.
    PubMed     Abstract available


  82. DETKE HC, Goadsby PJ, Wang S, Friedman DI, et al
    Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study.
    Neurology. 2018 Nov 16. pii: WNL.0000000000006640.
    PubMed     Abstract available


  83. KUCA B, Silberstein SD, Wietecha L, Berg PH, et al
    Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.
    Neurology. 2018 Nov 16. pii: WNL.0000000000006641.
    PubMed     Abstract available


  84. FRIDMAN S, Sposato LA
    Migraine with visual aura, incident AF, and stroke risk: Is migraine with aura an embolic TIA?
    Neurology. 2018 Nov 14. pii: WNL.0000000000006637.
    PubMed    


  85. SEN S, Androulakis XM, Duda V, Alonso A, et al
    Migraine with visual aura a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2018 Nov 14. pii: WNL.0000000000006650.
    PubMed     Abstract available


    August 2018
  86. VEREB D, Szabo N, Tuka B, Tajti J, et al
    Correlation of neurochemical and imaging markers in migraine: PACAP38 and DTI measures.
    Neurology. 2018 Aug 22. pii: WNL.0000000000006201.
    PubMed     Abstract available


  87. VANDERPLUYM J, Dodick DW, Lipton RB, Ma Y, et al
    Fremanezumab for preventive treatment of migraine: Functional status on headache-free days.
    Neurology. 2018 Aug 17. pii: 01.wnl.0000544321.19316.
    PubMed     Abstract available


    June 2018
  88. VAN OOSTERHOUT WPJ, Schoonman GG, van Zwet EW, Dekkers OM, et al
    Female sex hormones in men with migraine.
    Neurology. 2018 Jun 27. pii: WNL.0000000000005855.
    PubMed     Abstract available


  89. MESSINA R, Rocca MA, Colombo B, Pagani E, et al
    Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005819.
    PubMed     Abstract available


  90. TASSORELLI C, Grazzi L, de Tommaso M, Pierangeli G, et al
    Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.
    Neurology. 2018 Jun 15. pii: WNL.0000000000005857.
    PubMed     Abstract available


  91. LIPTON RB, Goadsby PJ
    Comment: Noninvasive neurostimulation for migraine should be part of the general neurologist's therapeutic armamentarium.
    Neurology. 2018 Jun 15. pii: WNL.0000000000005870.
    PubMed    


    April 2018
  92. SCHULTE LH, Allers A, May A
    Visual stimulation leads to activation of the nociceptive trigeminal nucleus in chronic migraine.
    Neurology. 2018 Apr 27. pii: WNL.0000000000005622.
    PubMed     Abstract available


    March 2018
  93. EL YOUSSEF N, Maalouf N, Mourad A, Saade J, et al
    Teaching NeuroImages: Retinal migraine in action.
    Neurology. 2018;90:e992.
    PubMed    


    January 2018
  94. PELZER N, Haan J, Stam AH, Vijfhuizen LS, et al
    Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation.
    Neurology. 2018 Jan 17. pii: WNL.0000000000004966.
    PubMed     Abstract available


    November 2017
  95. KOWALEC K, McKay KA, Patten SB, Fisk JD, et al
    Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004716.
    PubMed     Abstract available


    October 2017
  96. FRIEDMAN BW, Irizarry E, Solorzano C, Latev A, et al
    Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine.
    Neurology. 2017 Oct 18. pii: 10.1212/WNL.0000000000004642.
    PubMed     Abstract available


  97. PALM-MEINDERS IH, Arkink EB, Koppen H, Amlal S, et al
    Volumetric brain changes in migraineurs from the general population.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004640.
    PubMed     Abstract available


    August 2017
  98. FERRONI P, Barbanti P, Aurilia C, Egeo G, et al
    Procoagulant imbalance in premenopausal women with chronic migraine.
    Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004435.
    PubMed    


  99. ASHINA M, Dodick D, Goadsby PJ, Reuter U, et al
    Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004391.
    PubMed     Abstract available


  100. BEAR JJ, Gelfand AA, Goadsby PJ, Bass N, et al
    Occipital headaches and neuroimaging in children.
    Neurology. 2017;89:469-474.
    PubMed     Abstract available


    July 2017
  101. MULLER KI, Alstadhaug KB, Bekkelund SI
    A randomized trial of telemedicine efficacy and safety for nonacute headaches.
    Neurology. 2017;89:153-162.
    PubMed     Abstract available


  102. SCHER AI, Buse DC, Fanning KM, Kelly AM, et al
    Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004177.
    PubMed     Abstract available


    June 2017
  103. ANDROULAKIS XM, Krebs K, Peterlin BL, Zhang T, et al
    Modulation of intrinsic resting-state fMRI networks in women with chronic migraine.
    Neurology. 2017 Jun 14. pii: 10.1212/WNL.0000000000004089.
    PubMed     Abstract available


  104. DE JONG HJI, Kingwell E, Shirani A, Cohen Tervaert JW, et al
    Evaluating the safety of beta-interferons in MS: A series of nested case-control studies.
    Neurology. 2017;88:2310-2320.
    PubMed     Abstract available


    April 2017
  105. SCHULTE LH, Allers A, May A
    Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003963.
    PubMed     Abstract available


  106. GELAYE B, Sacco S, Brown WJ, Nitchie HL, et al
    Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003919.
    PubMed     Abstract available


    March 2017
  107. DASILVA AF, Nascimento TD, Jassar H, Heffernan J, et al
    Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003861.
    PubMed     Abstract available


  108. MONTEITH TS
    Migraine relief: Nonpainful stimulation for acute attacks.
    Neurology. 2017;88:e128-e131.
    PubMed    


  109. YARNITSKY D, Volokh L, Ironi A, Weller B, et al
    Nonpainful remote electrical stimulation alleviates episodic migraine pain.
    Neurology. 2017 Mar 1. pii: 10.1212/WNL.0000000000003760.
    PubMed     Abstract available


    December 2016
  110. ANDROULAKIS XM, Kodumuri N, Giamberardino LD, Rosamond WD, et al
    Ischemic stroke subtypes and migraine with visual aura in the ARIC study.
    Neurology. 2016;87:2527-2532.
    PubMed     Abstract available


  111. SPOSATO LA, Peterlin BL
    Cardioembolism as the unsuspected missing link between migraine and ischemic stroke.
    Neurology. 2016;87:2504-2505.
    PubMed    


    November 2016
  112. SETHI M, Kowalczyk MA, Dalic LJ, Archer JS, et al
    Abnormal neurovascular coupling during status epilepticus migrainosus in Sturge-Weber syndrome.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003492.
    PubMed    


  113. LOUTER MA, Pelzer N, de Boer I, Kuijvenhoven BE, et al
    Prevalence of lifetime depression in a large hemiplegic migraine cohort.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003376.
    PubMed     Abstract available


    October 2016
  114. DESOUZA DD, O'Hare M, Woldeamanuel YW, Cowan RP, et al
    Journal Club: Change in brain network connectivity during PACAP38-induced migraine attacks.
    Neurology. 2016;87:e199-e202.
    PubMed    


  115. WOLDEAMANUEL YW, O'Hare M, DeSouza DD, Cowan RP, et al
    Journal Club: Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.
    Neurology. 2016;87:e196-e198.
    PubMed     Abstract available


  116. COPPOLA G, Di Renzo A, Tinelli E, Di Lorenzo C, et al
    Thalamo-cortical network activity during spontaneous migraine attacks.
    Neurology. 2016 Oct 14. pii: 10.1212/WNL.0000000000003327.
    PubMed     Abstract available


  117. VERSLEGERS WR, Leone M, Proietti Cecchini A
    Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache.
    Neurology. 2016;87:1522-1523.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: